Malignant Neoplasm of Stomach Withdrawn Phase 1 Trials for Tesevatinib (DB11973)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02205463KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach CancerTreatment